Health Condition 1: M069- Rheumatoid arthritis, unspecified
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients willing to sign consent form for the clinical trial. 2. Patients between the age group of 18 to 60 years, irrespective of sex and socio-economic status. 3. Patients having signs and symptoms of â??Amavataâ?? (Rheumatoid Arthritis) 4. Patients fulfill the criteria of ACR/ EULAR 2010 criteria (American College of Rheumatology/ European League Against Rheumatism) 5. Patients with chronicity of less than 5 years.
Exclusion criteria
Exclusion criteria: 1. Patients having severe joint deformities. 2. Patients suffering from paralysis. 3. Patients having any type of arthropathy such as Neoplasm of spine, Gout, Ankylosing spondylosis, Traumatic arthritis and Pyogenic osteomyelitis etc. 4. Patients having associated Cardiac disease, Tuberculosis, Diabetes mellitus, Malignant Hypertension, Renal Function Impairment, Hypothyroidism, Rheumatic Heart Disease etc. 5. Patients with extremely reduced joint space. 6. Pregnant women and lactating mother. 7. Patient taking disease modifying anti-rheumatic drugs (DMARDs) for rheumatoid arthritis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in DAS- 28 score.Timepoint: 56 Days | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in symptoms of Amavata, Improvement in quality of life and changes in CRP, RA Factor, Disability Index Score, other symptoms, Improvement in walking time, hand & foot grip.Timepoint: 56 Days | — |
Countries
India
Contacts
National institute of Ayurveda Deemed to be University Jaipur